SCHEMBL29856233

SCHEMBL29856233

Cn1c(C(C)(C)C)c(C=O)c2ccncc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.39
ADORA3 P0DMS8 2/20 0.37
ADORA2A P29274 2/20 0.37
NFATC1 O95644 2/20 0.36
GSK3B P49841 2/20 0.36
DYRK1A Q13627 2/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
AAK1 Q2M2I8 2/20 0.34
CYP2A6 P11509 2/20 0.33
KDM5A P29375 1/20 0.33
CYP1A2 P05177 2/20 0.33
POLB P06746 2/20 0.33
CYP2C19 P33261 2/20 0.33
ROCK2 O75116 2/20 0.32
ADORA1 P30542 1/20 0.31
HTT P42858 4/20 0.31
MAPT P10636 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955564 0.78 ERN1 (0.41) ERN1ADORA3ADORA2ANFATC1GSK3B
SCHEMBL29856149 0.76 ERN1 (0.39) ERN1ADORA3ADORA2ANFATC1GSK3B
SCHEMBL6487514 0.74 ALDH1A1 (0.68) ERN1NFATC1GSK3BDYRK1AALDH1A1
SCHEMBL1609661 0.70 ADORA3 (0.54) ADORA3ADORA2ANFATC1GSK3BDYRK1A
SCHEMBL29856340 0.70 ROCK2 (0.38) ADORA3ADORA2ALMNAKDM5AROCK2
SCHEMBL22346601 0.69 KDM4E (0.53) ADORA3ADORA2AALDH1A1LMNAKDM5A
SCHEMBL29856173 0.66 ADORA3 (0.40) ADORA3ADORA2AALDH1A1LMNAKDM5A
SCHEMBL9968101 0.66 ADORA3 (0.44) ADORA3ADORA2ANFATC1GSK3BDYRK1A
SCHEMBL29951384 0.66 ERN1 (0.37) ERN1ALDH1A1LMNACYP2A6CYP1A2
SCHEMBL29935691 0.65 ALDH1A1 (0.59) ERN1NFATC1GSK3BDYRK1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed